“…In this study diminished muscle levels of insulin-like growth factor-I (mIGF-I) were identified in our RA patients. This finding is consistent with reports of reduced mIGF-I levels in other conditions characterised by muscle wasting: chronic heart failure (CHF) (Hambrecht et al, 2005), chronic obstructive pulmonary disease (COPD) (Vogiatzis et al, 2007), chronic renal failure (Macdonald et al, 2004(Macdonald et al, , 2005, and advanced aging (Fiatarone Singh et al, 1999); and with the proposed role of mIGF-I in regulating the maintenance of adult skeletal muscle (Adams, 2002). Following 24 weeks PRT, along with muscle hypertrophy, mIGF-I levels were observed to increase 50% in our RA patients.…”